RARA CRAFT DATABASE for FDA Medical Devices
510(k)K143599

FDA DEVICE FACTS

Chemtrue Drug Screen Cup Tests and Chemtrue Drug Screen Cup Tests with OPI 2000

Chemtron Biotech, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 17, 2015PRODUCT CODEDJG

Indications for use

The Chemtrue® Drug Screen Cup Tests are rapid lateral flow immunoassays for the qualitative detection of Buprenorphine, Amphetamine, Cocaine, Marijuana, Morphine 300, Methamphetamine, Phencyclidine, Benzodiazepines, Barbiturates, Ecstasy, Methadone, Oxycodone and Tricyclic Antidepressants drugs in human urine. The test cut-off concentrations and the compounds the tests are calibrated to are as follows: Analyte Abbreviation Calibrator Cutoff Concentration (ng/mL) Buprenorphine BUP Buprenorphine 10 Tricyclic Antidepressants TCA Nortriptyline 1000 Amphetamine AMP d-Amphetamine 1000 Cocaine COC Benzoylecgonine 300 Methamphetamine MAMP /MET d-Methamphetamine 1000 Morphine MOR Morphine 300 Phencyclidine PCP Phencyclidine 25 Marijuana THC 11-nor-Δ9-THC-9-COOH 50 Benzodiazepines BZO Oxazepam 300 Barbiturates BAR Secobarbital/Pentobarbital 300 Ecstasy MDMA d,l-Methylenedioxymethamphetamine 500 Methadone MTD Methadone 300 Oxycodone OXY Oxycodone 100 The Chemtrue® Drug Screen Cup Tests panel can consist of any combination of the above listed drug analytes. The tests are intended for prescription and Over-The-Counter (OTC) use. The tests provide only a preliminary result. A more specific alternative chemical method must be used in order to obtain a confirmed assay result. Gas Chromatography / Mass Spectrometry (GC/MS) or Liquid Chromatography / Mass Spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drugs of abuse test result, particularly when preliminary positive results are indicated. The tests are not intended to differentiate between drugs of abuse and prescription use of Benzodiazepines, Barbiturates, Buprenorphine, Oxycodone and Tricyclic Antidepressants. There are no uniformly recognized cut-off concentration levels for these drugs in urine. The Chemtrue® Drug Screen Cup Tests with OPI 2000 are rapid lateral flow immunoassays for the qualitative detection of Buprenorphine, Amphetamine, Cocaine, Marijuana, Opiates 2000, Methamphetamine, Phencyclidine, Benzodiazepines, Barbiturates, Ecstasy, Methadone, Oxycodone and Tricyclic Antidepressants drugs in human urine. The test cut-off concentrations and the compounds the tests are calibrated to are as follows: Analyte Abbreviation Calibrator Cutoff Concentration (ng/mL) Buprenorphine BUP Buprenorphine 10 Tricyclic Antidepressants TCA Nortriptyline 1000 Amphetamine AMP d-Amphetamine 1000 Cocaine COC Benzoylecgonine 300 Methamphetamine MAMP /MET d-Methamphetamine 1000 Opiates 2000 OPI Morphine 2000 Phencyclidine PCP Phencyclidine 25 Marijuana THC 11-nor-Δ9-THC-9-COOH 50 Benzodiazepines BZO Oxazepam 300 Barbiturates BAR Secobarbital/Pentobarbital 300 Ecstasy MDMA d,l-Methylenedioxymethamphetamine 500 Methadone MTD Methadone 300 Oxycodone OXY Oxycodone 100 The Chemtrue® Drug Screen Cup Tests with OPI 2000 panel can consist of any combination of the above listed drug analytes. The tests are intended for prescription and Over-The-Counter (OTC) use. The tests provide only a preliminary result. A more specific alternative chemical method must be used in order to obtain a confirmed assay result. Gas Chromatography / Mass Spectrometry (GC/MS) or Liquid Chromatography / Mass Spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drugs of abuse test result, particularly when preliminary positive results are indicated. The tests are not intended to differentiate between drugs of abuse and prescription use of Benzodiazepines, Barbiturates, Buprenorphine, Oxycodone and Tricyclic Antidepressants. There are no uniformly recognized cut-off concentration levels for these drugs in urine.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 6, 2026